Snapshot from Jul 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech clinical trial

Auriculotherapy for chronic migraine study

Analysis based on 7 articles · First reported Jul 09, 2026 · Last updated Jul 12, 2026

Sentiment
10
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study is unlikely to have immediate market impact. If confirmed in larger trials, auriculotherapy could become a complementary treatment for migraine, potentially affecting the migraine drug market.

healthcare

A randomized clinical trial presented at the Federation of European Neuroscience Societies (FENS) Forum 2026 investigated auriculotherapy (ear acupuncture) for chronic migraine. Led by Fernanda Belle of the University of Southern Santa Catarina (UNISUL), Brazil, the study involved 68 women with chronic migraine. Participants received either auriculotherapy or a sham procedure over eight weeks. Both groups reported reduced pain and improved daily function, but no statistically significant difference was found between groups. Researchers observed changes in prefrontal cortex oxygenation via hemoencephalography. The findings are considered preliminary, and larger studies are planned.

40 Fernanda Belle led clinical trial
per
Lead researcher and presenter; personal experience with migraines motivated the study.
Importance 70.0 Sentiment 10.0
oth
Conducted the clinical trial; positive publicity for research on complementary migraine therapy.
Importance 60.0 Sentiment 10.0
ngo
Hosted the FENS Forum 2026 where the research was presented.
Importance 30.0 Sentiment 0.0
per
Independent expert who commented on the study's methodology.
Importance 20.0 Sentiment 0.0
cnt
Country where the research was conducted; no direct impact.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.